Compare RS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RS | HOLX |
|---|---|---|
| Founded | 1939 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 16.6B |
| IPO Year | 1996 | 1995 |
| Metric | RS | HOLX |
|---|---|---|
| Price | $298.56 | $75.65 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 13 |
| Target Price | ★ $328.50 | $77.89 |
| AVG Volume (30 Days) | 314.7K | ★ 2.9M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.67% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 13.98 | 0.79 |
| Revenue | ★ $14,805,900,000.00 | $4,100,500,000.00 |
| Revenue This Year | $9.32 | $4.74 |
| Revenue Next Year | $1.11 | $5.03 |
| P/E Ratio | ★ $21.45 | $95.64 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $250.07 | $51.90 |
| 52 Week High | $365.59 | $75.75 |
| Indicator | RS | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 60.71 |
| Support Level | $287.99 | $75.10 |
| Resistance Level | $335.13 | N/A |
| Average True Range (ATR) | 7.36 | 0.20 |
| MACD | 0.52 | 0.02 |
| Stochastic Oscillator | 52.60 | 86.67 |
Reliance Inc operates a network of companies providing diversified metal solutions and is the metals service center company. It distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium and other specialty steel products. The company services more than 125,000 customers in a variety of industries, including consumer products, general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, industrial machinery and heavy industry. It also services the auto industry, through its toll processing operations where it processes customer-owned metal for a fee.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.